Innovative medicines for the treatment of hormonally-driven cancers. Aisling congratulates the management teams of Aragon and Seragon on their recent acquisitions by Johnson and Johnson and Genentech, respectively. Learn More About Aragon and Seragon. Largest provider of biopharmaceutical development and commercial outsourcing services. Learn More About T2 Biosystems.

Your browser does not support the. Your browser does not support the. DMG defies the limitations of traditional communications agencies. Providing the expert attention you and your projects deserve. This is absolutely perfect and captures the emotion we are looking for. Associate Director, Marketing Programs. Thank You All So Much! Working with you has been one of the best professional decisions I have made in my entire career.

EUCOPE provides a platform for discussion for pharmaceutical entrepreneurs. On a regular basis owners and CEOs of pharmaceutical companies and associations discuss solutions to improve the quality of life for patients and to strengthen the competitiveness of the European pharmaceutical industry. Commission assessment of the regulatory incentives for the development of medicinal products. EU cooperation on Health Technology Assessment.

Food Allergies impact the lives of over 15 million Americans. This epidemic is rising at an alarming rate. Although the number of children being diagnosed with food allergies is reaching epidemic proportions, relatively little money is being invested into research for a cure. Roughly 2 children in every classroom have a food allergy.

From due diligence and acquisition integration to complex accounting transactions and IPO prep. Together with our CEOs and Boards, we deliver leadership, strategic advice and insights that move the needle around positive business outcomes for our clients. Funding rounds and the value of your enterprise. Our experience, expertise and leadership. FLG Partners delivers superior value.

We provide catalytic capital to transformative healthcare companies at all stages. Democratizing access to high quality genetic information. Reversing Tumors Associated With Immunosuppression. Revolutionizing Type 2 Diabetes and Obesity Treatment. Protecting People From Food Allergens. Addressing Glaucoma With Triple-Action Eyedrops. Changing the Definition of Sequencing.

We invest in both privately held and publicly traded life science companies through a variety of investment approaches. 2 billion across three funds and demonstrated an ability to source, manage and exit attractive investments across multi.

Aimmune Therapeutics a 35th Annual J. Aimmune Therapeutics a 35th Annual J. Click here to add this event to your calendar. Aimmune Therapeutics to Present at the 35th Annual J.